Abstract

Insecticidal fungi represent a promising alternative to chemical pesticides for disease vector control. Here, we show that the pathogenic fungus Beauveria bassiana exports a microRNA-like RNA (bba-milR1) that hijacks the host RNA-interference machinery in mosquito cells by binding to Argonaute 1 (AGO1). bba-milR1 is highly expressed during fungal penetration of the mosquito integument, and suppresses host immunity by silencing expression of the mosquito Toll receptor ligand Spätzle 4 (Spz4). Later, upon entering the hemocoel, bba-milR1 expression is decreased, which avoids induction of the host proteinase CLIPB9 that activates the melanization response. Thus, our results indicate that the pathogen deploys a cross-kingdom small-RNA effector that attenuates host immunity and facilitates infection.

Highlights

  • Insecticidal fungi represent a promising alternative to chemical pesticides for disease vector control

  • We identified four miRNA-like small RNAs whose sequences cannot be mapped to the A. stephensi genome, but perfectly matched the B. bassiana genome (Supplementary Fig. 1a)

  • These results indicate that miRNAs produced by B. bassiana are exported into host cells and bind to mosquito Argonaute 1 (AGO1) to hijack host the RNA interference (RNAi) machinery

Read more

Summary

Introduction

Insecticidal fungi represent a promising alternative to chemical pesticides for disease vector control. The insect pathogenic fungus Beauveria bassiana (Cordycipitaceae) offers a promising environment-friendly alternative to chemical insecticides[5,6]. This fungus is effective at killing both insecticide-resistant and -susceptible adult mosquitoes[7,8] and considered as a next-generation mosquito control agent[9,10]. Toll is the principal antifungal pathway by directing the production of antifungal peptides[12] Melanization is another important facet of the mosquito immune defense against fungi[13]. To our knowledge, no examples of such effector molecules have been described for insect pathogenic fungi[20]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.